Industry Interview Series: Dr. Aris Persidis, President and Co-founder, Biovista, Inc.
Online article in Pharmaceutical Engineering Magazine.
Read More…With patent expirations looming for many major pharmaceutical companies, drug repositioning has become a matter of intense interest during the past few years. Biovista’s President and Co-founder discusses the basics of drug repositioning and the potential impact it could have on bringing new drugs to the market.
…